175 related articles for article (PubMed ID: 10438377)
21. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
Banker AS; Patel A
Indian J Ophthalmol; 2002 Mar; 50(1):29-33. PubMed ID: 12090084
[TBL] [Abstract][Full Text] [Related]
22. Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.
Salmon-Céron D; Fillet AM; Aboulker JP; Gérard L; Houhou N; Carrière I; Ostinelli J; Vildé JL; Brun-Vézinet F; Leport C
Clin Infect Dis; 1999 Apr; 28(4):901-5. PubMed ID: 10825058
[TBL] [Abstract][Full Text] [Related]
23. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
[TBL] [Abstract][Full Text] [Related]
24. CMV after HAART.
Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
[TBL] [Abstract][Full Text] [Related]
25. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
26. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
27. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
[TBL] [Abstract][Full Text] [Related]
28. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Weinberg A; Wohl DA; Barrett RJ; van der Horst C
J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes and immune reconstitution in 103 advanced AIDS patients undergoing 12-month highly active antiretroviral therapy.
Dai Y; Qiu ZF; Li TS; Han Y; Zuo LY; Xie J; Ma XJ; Liu ZY; Wang AX
Chin Med J (Engl); 2006 Oct; 119(20):1677-82. PubMed ID: 17097013
[TBL] [Abstract][Full Text] [Related]
30. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
31. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
[TBL] [Abstract][Full Text] [Related]
32. Response of asymptomatic cytomegalovirus viraemia to oral ganciclovir 3 g/day or 6 g/day in HIV-infected patients.
Grzywacz M; Deayton JR; Bowen EF; Wilson P; Emery VC; Johnson MA; Griffiths PD
J Med Virol; 1999 Nov; 59(3):323-8. PubMed ID: 10502264
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
Pessôa MG; Gazzard B; Huang AK; Brandão-Mello CE; Cassetti I; Mendes-Corrêa MC; Soriano V; Phiri P; Hall A; Brett-Smith H
AIDS; 2008 Sep; 22(14):1779-87. PubMed ID: 18753861
[TBL] [Abstract][Full Text] [Related]
34. [Advances in the diagnosis and treatment of infections caused by herpesvirus and JC virus].
Arribas JR; Arrizabalaga J; Mallolas J; López-Cortés LF
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():11-9. PubMed ID: 9859615
[TBL] [Abstract][Full Text] [Related]
35. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
36. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.
Gourlain K; Salmon D; Gault E; Leport C; Katlama C; Matheron S; Costagliola D; Mazeron MC; Fillet AM; ;
J Med Virol; 2003 Mar; 69(3):401-7. PubMed ID: 12526052
[TBL] [Abstract][Full Text] [Related]
38. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
39. Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy.
Focà E; Motta D; Pollara C; Brianese N; Gotti D; Albini L; Quiros-Roldan E; Torti C; Manca N
New Microbiol; 2012 Apr; 35(2):227-31. PubMed ID: 22707137
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
